Rivastigmine
Exelon, Prometax, Rivastigmine 1 A Pharma, Rivastigmine Hexal, Rivastigmine Sandoz (rivastigmine) is a small molecule pharmaceutical. Rivastigmine was first approved as Exelon on 1998-05-11. It is used to treat alzheimer disease in the USA. It has been approved in Europe to treat alzheimer disease, dementia, and parkinson disease. The pharmaceutical is active against acetylcholinesterase and cholinesterase.
Trade Name | Exelon, Prometax, Rivastigmine 1 A Pharma, Rivastigmine Hexal, Rivastigmine Sandoz |
---|---|
Common Name | Rivastigmine |
Indication | alzheimer disease, dementia, parkinson disease |
Drug Class | Cholinesterase inhibitors (physostigmine type) |